Skip to main content
B

Bactolife

Bactolife develops Binding Proteins that enhance gut microbiome health by targeting harmful microbes and their metabolites, addressing the global issue of antimicrobial resistance. Their solutions aim to improve health outcomes for both humans and animals by promoting a balanced gut environment.

Kongens Lyngby, DenmarkFounded 2017597K+ followers
Updated 20 months ago

Funding

$44.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

A
Funding rounds are not available yet.

Founders

Product

Problem

The overuse of antimicrobials is leading to a rise in antimicrobial resistance, threatening the effectiveness of treatments for infectious diseases in both humans and animals. Maintaining a healthy gut microbiome is crucial for overall health, but it is often disrupted by harmful microbes and their metabolites.

Solution

Bactolife develops Binding Proteins designed to selectively target and neutralize harmful microbes and their metabolites within the gut, promoting a balanced and healthy gut microbiome. These Binding Proteins offer a targeted approach to modulate the gut environment, supporting overall health and well-being. By addressing the root cause of gut imbalance, Bactolife aims to reduce the reliance on broad-spectrum antimicrobials and mitigate the development of antimicrobial resistance. Their technology offers a proactive strategy for improving gut health and preventing dysbiosis. Bactolife's Binding Proteins can be integrated into various applications for both human and animal health.

Target Audience

Bactolife's primary customers include individuals seeking to improve their gut health and reduce their reliance on antimicrobials, as well as animal health companies looking for innovative solutions to promote gut health in livestock and pets.

Features

  • Selectively binds to harmful microbes and their metabolites in the gut
  • Promotes a balanced and healthy gut microbiome
  • Reduces the need for broad-spectrum antimicrobials
  • Helps to mitigate the development of antimicrobial resistance
  • Can be integrated into various applications for human and animal health
This profile is AI-generated and may contain inaccuracies.